

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | cilium or flagellum-dependent cell motility (GO:0001539) | 5.18852422 |
| 2 | glomerular visceral epithelial cell development (GO:0072015) | 5.16677479 |
| 3 | glomerular epithelial cell development (GO:0072310) | 4.86404996 |
| 4 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 4.75693602 |
| 5 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 4.75693602 |
| 6 | modulation by symbiont of host immune response (GO:0052553) | 4.75693602 |
| 7 | positive regulation by symbiont of host defense response (GO:0052509) | 4.75693602 |
| 8 | modulation by symbiont of host defense response (GO:0052031) | 4.75693602 |
| 9 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 4.75693602 |
| 10 | glomerular basement membrane development (GO:0032836) | 4.27903503 |
| 11 | epithelial cilium movement involved in determination of left/right asymmetry (GO:0060287) | 4.20771159 |
| 12 | cilium movement (GO:0003341) | 3.96143012 |
| 13 | axonemal dynein complex assembly (GO:0070286) | 3.94659177 |
| 14 | cell adhesion mediated by integrin (GO:0033627) | 3.82643058 |
| 15 | epithelial cilium movement (GO:0003351) | 3.78832960 |
| 16 | regulation of interferon-beta biosynthetic process (GO:0045357) | 3.70525812 |
| 17 | macrophage activation involved in immune response (GO:0002281) | 3.58671492 |
| 18 | protein localization to endosome (GO:0036010) | 3.43307928 |
| 19 | positive regulation of p38MAPK cascade (GO:1900745) | 3.36121578 |
| 20 | apoptotic cell clearance (GO:0043277) | 3.17710715 |
| 21 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 3.13640659 |
| 22 | response to host immune response (GO:0052572) | 3.13640659 |
| 23 | motile cilium assembly (GO:0044458) | 3.04857378 |
| 24 | pyrimidine nucleobase catabolic process (GO:0006208) | 3.04529842 |
| 25 | positive regulation of mast cell activation involved in immune response (GO:0033008) | 3.03565448 |
| 26 | positive regulation of mast cell degranulation (GO:0043306) | 3.03565448 |
| 27 | cellular response to follicle-stimulating hormone stimulus (GO:0071372) | 3.02585353 |
| 28 | response to defenses of other organism involved in symbiotic interaction (GO:0052173) | 3.02502808 |
| 29 | response to host (GO:0075136) | 3.02502808 |
| 30 | response to host defenses (GO:0052200) | 3.02502808 |
| 31 | positive regulation of mast cell activation (GO:0033005) | 3.00909539 |
| 32 | nucleobase catabolic process (GO:0046113) | 2.99569266 |
| 33 | response to lipoprotein particle (GO:0055094) | 2.96288292 |
| 34 | positive regulation of interleukin-8 biosynthetic process (GO:0045416) | 2.93094800 |
| 35 | microglial cell activation (GO:0001774) | 2.92988868 |
| 36 | organic cation transport (GO:0015695) | 2.91788669 |
| 37 | positive regulation of membrane protein ectodomain proteolysis (GO:0051044) | 2.86806104 |
| 38 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 2.85942939 |
| 39 | drug transmembrane transport (GO:0006855) | 2.84161598 |
| 40 | toxin transport (GO:1901998) | 2.81851660 |
| 41 | axoneme assembly (GO:0035082) | 2.80265100 |
| 42 | protein localization to cilium (GO:0061512) | 2.77002708 |
| 43 | neutrophil activation involved in immune response (GO:0002283) | 2.76653915 |
| 44 | surfactant homeostasis (GO:0043129) | 2.75129378 |
| 45 | regulation of membrane protein ectodomain proteolysis (GO:0051043) | 2.73273622 |
| 46 | urate metabolic process (GO:0046415) | 2.70703374 |
| 47 | stress fiber assembly (GO:0043149) | 2.68716403 |
| 48 | negative regulation of interleukin-12 production (GO:0032695) | 2.67859924 |
| 49 | proline transport (GO:0015824) | 2.67526712 |
| 50 | macroautophagy (GO:0016236) | 2.61983819 |
| 51 | regulation of integrin-mediated signaling pathway (GO:2001044) | 2.60342020 |
| 52 | negative regulation of mast cell activation (GO:0033004) | 2.60017689 |
| 53 | aminoglycoside antibiotic metabolic process (GO:0030647) | 2.57234165 |
| 54 | keratan sulfate catabolic process (GO:0042340) | 2.56085496 |
| 55 | positive regulation of phosphoprotein phosphatase activity (GO:0032516) | 2.54981680 |
| 56 | phosphate ion transport (GO:0006817) | 2.54174251 |
| 57 | regulation of mast cell activation (GO:0033003) | 2.53772019 |
| 58 | T-helper 1 type immune response (GO:0042088) | 2.52208475 |
| 59 | regulation of p38MAPK cascade (GO:1900744) | 2.48278081 |
| 60 | response to thyroid hormone (GO:0097066) | 2.48268847 |
| 61 | estrogen biosynthetic process (GO:0006703) | 2.47428654 |
| 62 | detection of molecule of bacterial origin (GO:0032490) | 2.46796824 |
| 63 | sodium ion export (GO:0071436) | 2.46339704 |
| 64 | neural tube formation (GO:0001841) | 2.43659522 |
| 65 | L-amino acid import (GO:0043092) | 2.43221749 |
| 66 | I-kappaB phosphorylation (GO:0007252) | 2.42428201 |
| 67 | cellular response to vitamin (GO:0071295) | 2.42415628 |
| 68 | wound healing, spreading of epidermal cells (GO:0035313) | 2.41937605 |
| 69 | mannose metabolic process (GO:0006013) | 2.41315345 |
| 70 | cellular extravasation (GO:0045123) | 2.41284358 |
| 71 | excretion (GO:0007588) | 2.40489912 |
| 72 | cytoskeletal anchoring at plasma membrane (GO:0007016) | 2.40164186 |
| 73 | quaternary ammonium group transport (GO:0015697) | 2.37958594 |
| 74 | regulation of mast cell activation involved in immune response (GO:0033006) | 2.37918478 |
| 75 | macrophage activation (GO:0042116) | 2.36860120 |
| 76 | peptide catabolic process (GO:0043171) | 2.35947242 |
| 77 | positive regulation of macrophage cytokine production (GO:0060907) | 2.35727160 |
| 78 | positive regulation of leukocyte degranulation (GO:0043302) | 2.35028445 |
| 79 | androgen biosynthetic process (GO:0006702) | 2.33051858 |
| 80 | positive regulation of cell adhesion mediated by integrin (GO:0033630) | 2.32803059 |
| 81 | drug transport (GO:0015893) | 2.32637656 |
| 82 | negative regulation of hydrogen peroxide-induced cell death (GO:1903206) | 2.31967230 |
| 83 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 2.31830221 |
| 84 | negative regulation of cell killing (GO:0031342) | 2.31830221 |
| 85 | benzene-containing compound metabolic process (GO:0042537) | 2.31796271 |
| 86 | cellular response to thyroid hormone stimulus (GO:0097067) | 2.30783053 |
| 87 | amyloid precursor protein catabolic process (GO:0042987) | 2.30427871 |
| 88 | activated T cell proliferation (GO:0050798) | 2.30081237 |
| 89 | glucocorticoid biosynthetic process (GO:0006704) | 2.29600366 |
| 90 | regulation of heat generation (GO:0031650) | 2.29522786 |
| 91 | regulation of early endosome to late endosome transport (GO:2000641) | 2.29492316 |
| 92 | toxin metabolic process (GO:0009404) | 2.28694893 |
| 93 | positive regulation of cellular amide metabolic process (GO:0034250) | 2.28591865 |
| 94 | regulation of alkaline phosphatase activity (GO:0010692) | 2.28299470 |
| 95 | negative regulation of interleukin-1 beta production (GO:0032691) | 2.26809184 |
| 96 | cellular potassium ion homeostasis (GO:0030007) | 2.26791428 |
| 97 | cilium organization (GO:0044782) | 2.26328485 |
| 98 | regulation of interferon-alpha production (GO:0032647) | 2.25718616 |
| 99 | growth hormone receptor signaling pathway (GO:0060396) | 2.25712365 |
| 100 | regulation of cholesterol storage (GO:0010885) | 2.25320728 |
| 101 | cellular response to vitamin D (GO:0071305) | 2.25320598 |
| 102 | negative regulation of amyloid precursor protein catabolic process (GO:1902992) | 2.24234460 |
| 103 | regulation of clathrin-mediated endocytosis (GO:2000369) | 2.23610227 |
| 104 | cilium assembly (GO:0042384) | 2.22635687 |
| 105 | bone resorption (GO:0045453) | 2.21983906 |
| 106 | regulation of cilium movement (GO:0003352) | 2.21225327 |
| 107 | hydrogen peroxide biosynthetic process (GO:0050665) | 2.20829897 |
| 108 | regulation of mast cell degranulation (GO:0043304) | 2.20662695 |
| 109 | semaphorin-plexin signaling pathway (GO:0071526) | 2.20521437 |
| 110 | nerve growth factor signaling pathway (GO:0038180) | 2.20372099 |
| 111 | lipoprotein transport (GO:0042953) | 2.20306667 |
| 112 | positive regulation of osteoblast proliferation (GO:0033690) | 2.19961154 |
| 113 | positive regulation of toll-like receptor signaling pathway (GO:0034123) | 2.19512945 |
| 114 | cellular response to growth hormone stimulus (GO:0071378) | 2.18916301 |
| 115 | positive regulation of myeloid leukocyte mediated immunity (GO:0002888) | 2.18764816 |
| 116 | clathrin coat assembly (GO:0048268) | 2.18220029 |
| 117 | negative regulation of interleukin-1 production (GO:0032692) | 2.17960475 |
| 118 | regulation of macrophage cytokine production (GO:0010935) | 2.16958980 |
| 119 | glycoside metabolic process (GO:0016137) | 2.16488841 |
| 120 | glycosphingolipid biosynthetic process (GO:0006688) | 2.16357564 |
| 121 | superoxide anion generation (GO:0042554) | 2.16109119 |
| 122 | positive regulation of heat generation (GO:0031652) | 2.15314297 |
| 123 | intraciliary transport (GO:0042073) | 2.14770644 |
| 124 | negative regulation of response to reactive oxygen species (GO:1901032) | 2.14427147 |
| 125 | negative regulation of immunoglobulin mediated immune response (GO:0002890) | 2.14222043 |
| 126 | negative regulation of B cell mediated immunity (GO:0002713) | 2.14222043 |
| 127 | fibroblast migration (GO:0010761) | 2.14151505 |
| 128 | renal filtration (GO:0097205) | 2.13497025 |
| 129 | phosphate ion transmembrane transport (GO:0035435) | 2.13312469 |
| 130 | ganglioside metabolic process (GO:0001573) | 2.12230487 |
| 131 | cellular response to antibiotic (GO:0071236) | 2.12211182 |
| 132 | presynaptic membrane assembly (GO:0097105) | 2.11994926 |
| 133 | behavioral response to nicotine (GO:0035095) | 2.11745856 |
| 134 | intracellular lipid transport (GO:0032365) | 2.10465196 |
| 135 | phagosome maturation (GO:0090382) | 2.10453116 |
| 136 | positive regulation of interferon-alpha production (GO:0032727) | 2.09617112 |
| 137 | negative regulation of cytosolic calcium ion concentration (GO:0051481) | 2.09396688 |
| 138 | regulation of microtubule-based movement (GO:0060632) | 2.09249268 |
| 139 | cell wall macromolecule catabolic process (GO:0016998) | 2.09040403 |
| 140 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 2.08591388 |
| 141 | vitamin D metabolic process (GO:0042359) | 2.08436408 |
| 142 | regulation of fever generation (GO:0031620) | 2.08062296 |
| 143 | regulation of hydrogen peroxide-induced cell death (GO:1903205) | 2.07953412 |
| 144 | cell wall macromolecule metabolic process (GO:0044036) | 2.07495862 |
| 145 | reactive oxygen species biosynthetic process (GO:1903409) | 2.06876871 |
| 146 | response to peptidoglycan (GO:0032494) | 2.06689984 |
| 147 | brain morphogenesis (GO:0048854) | 2.06100542 |
| 148 | cerebellar Purkinje cell differentiation (GO:0021702) | 2.05614012 |
| 149 | left/right axis specification (GO:0070986) | 2.05578140 |
| 150 | nonmotile primary cilium assembly (GO:0035058) | 2.05518671 |
| 151 | interleukin-6-mediated signaling pathway (GO:0070102) | 2.04696750 |
| 152 | calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules (GO:0016339) | 2.04068800 |
| 153 | amino sugar catabolic process (GO:0046348) | 2.03090020 |
| 154 | presynaptic membrane organization (GO:0097090) | 2.02822529 |
| 155 | positive regulation of male gonad development (GO:2000020) | 2.02426051 |
| 156 | sulfation (GO:0051923) | 2.02308430 |
| 157 | response to fluid shear stress (GO:0034405) | 2.02133299 |
| 158 | neutrophil activation (GO:0042119) | 2.02068188 |
| 159 | positive regulation of cyclin-dependent protein serine/threonine kinase activity involved in G1/S tr | 2.02027538 |
| 160 | dichotomous subdivision of an epithelial terminal unit (GO:0060600) | 2.01598737 |
| 161 | positive regulation of bone resorption (GO:0045780) | 2.01435993 |
| 162 | positive regulation of bone remodeling (GO:0046852) | 2.01435993 |
| 163 | endocytic recycling (GO:0032456) | 2.00638770 |
| 164 | axonal fasciculation (GO:0007413) | 2.00546241 |
| 165 | amino acid import (GO:0043090) | 2.00467909 |
| 166 | positive regulation of regulated secretory pathway (GO:1903307) | 2.00254680 |
| 167 | regulation of beta-amyloid formation (GO:1902003) | 2.00247957 |
| 168 | metanephric epithelium development (GO:0072207) | 2.00041203 |
| 169 | granulocyte activation (GO:0036230) | 1.99585965 |
| 170 | regulation of mononuclear cell migration (GO:0071675) | 1.99441238 |
| 171 | leukocyte migration involved in inflammatory response (GO:0002523) | 1.99420655 |
| 172 | basement membrane organization (GO:0071711) | 1.99222347 |
| 173 | cilium morphogenesis (GO:0060271) | 1.98972665 |
| 174 | neutrophil mediated immunity (GO:0002446) | 1.98920740 |
| 175 | parturition (GO:0007567) | 1.98354670 |
| 176 | cellular response to ethanol (GO:0071361) | 1.98077982 |
| 177 | glucocorticoid metabolic process (GO:0008211) | 1.97798256 |
| 178 | response to mercury ion (GO:0046689) | 1.96845922 |
| 179 | regulation of male gonad development (GO:2000018) | 1.96557129 |
| 180 | regulation of MHC class II biosynthetic process (GO:0045346) | 1.96501795 |
| 181 | progesterone metabolic process (GO:0042448) | 1.96293449 |
| 182 | metanephric nephron epithelium development (GO:0072243) | 1.95526539 |
| 183 | positive regulation of syncytium formation by plasma membrane fusion (GO:0060143) | 1.95439904 |
| 184 | myeloid cell activation involved in immune response (GO:0002275) | 1.95364830 |
| 185 | prostate gland growth (GO:0060736) | 1.95268945 |
| 186 | epithelial cell differentiation involved in prostate gland development (GO:0060742) | 1.95240854 |
| 187 | neurotransmitter-gated ion channel clustering (GO:0072578) | 1.94030287 |
| 188 | regulation of tolerance induction (GO:0002643) | 1.93916230 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 2.81778176 |
| 2 | EZH2_22144423_ChIP-Seq_EOC_Human | 2.74117401 |
| 3 | GBX2_23144817_ChIP-Seq_PC3_Human | 2.63566664 |
| 4 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 2.34359052 |
| 5 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 2.25335237 |
| 6 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 2.22301333 |
| 7 | * SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.22064982 |
| 8 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 2.15976042 |
| 9 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 2.12384208 |
| 10 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 2.12079928 |
| 11 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 2.06084439 |
| 12 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 2.05208190 |
| 13 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 2.01041748 |
| 14 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.93421363 |
| 15 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.91646797 |
| 16 | TAF15_26573619_Chip-Seq_HEK293_Human | 1.88514859 |
| 17 | VDR_22108803_ChIP-Seq_LS180_Human | 1.79263474 |
| 18 | * IGF1R_20145208_ChIP-Seq_DFB_Human | 1.78500140 |
| 19 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 1.76531448 |
| 20 | * CTBP2_25329375_ChIP-Seq_LNCAP_Human | 1.73686786 |
| 21 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.73088557 |
| 22 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.70834416 |
| 23 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 1.70135475 |
| 24 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.69683050 |
| 25 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.68102712 |
| 26 | * PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.67437270 |
| 27 | * P300_19829295_ChIP-Seq_ESCs_Human | 1.62376026 |
| 28 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 1.60358027 |
| 29 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 1.60075094 |
| 30 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.57061438 |
| 31 | SMAD4_21799915_ChIP-Seq_A2780_Human | 1.55015342 |
| 32 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 1.54456316 |
| 33 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.52752064 |
| 34 | ZNF274_21170338_ChIP-Seq_K562_Hela | 1.50402610 |
| 35 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.49963113 |
| 36 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.49942288 |
| 37 | * CTBP1_25329375_ChIP-Seq_LNCAP_Human | 1.49081288 |
| 38 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.46532077 |
| 39 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 1.43027377 |
| 40 | * OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.41159661 |
| 41 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 1.39141134 |
| 42 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.38764649 |
| 43 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.38673552 |
| 44 | * WT1_25993318_ChIP-Seq_PODOCYTE_Human | 1.38301901 |
| 45 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.38184700 |
| 46 | * TOP2B_26459242_ChIP-Seq_MCF-7_Human | 1.37566340 |
| 47 | SPI1_23127762_ChIP-Seq_K562_Human | 1.36745203 |
| 48 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 1.36474504 |
| 49 | TEAD4_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.35890989 |
| 50 | POU5F1_26923725_Chip-Seq_MESODERM_Mouse | 1.35890989 |
| 51 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 1.34549640 |
| 52 | AHR_22903824_ChIP-Seq_MCF-7_Human | 1.33961793 |
| 53 | WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 1.33863157 |
| 54 | * ER_23166858_ChIP-Seq_MCF-7_Human | 1.33260696 |
| 55 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 1.33010895 |
| 56 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 1.33010895 |
| 57 | * SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 1.32695617 |
| 58 | * NR3C1_21868756_ChIP-Seq_MCF10A_Human | 1.31581623 |
| 59 | STAT3_23295773_ChIP-Seq_U87_Human | 1.30271104 |
| 60 | CJUN_26792858_Chip-Seq_BT549_Human | 1.28254099 |
| 61 | RXR_22108803_ChIP-Seq_LS180_Human | 1.27988025 |
| 62 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.27480884 |
| 63 | AR_25329375_ChIP-Seq_VCAP_Human | 1.27113657 |
| 64 | * TAL1_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.27059413 |
| 65 | MEIS1_26253404_ChIP-Seq_OPTIC_CUPS_Mouse | 1.25894677 |
| 66 | * EP300_21415370_ChIP-Seq_HL-1_Mouse | 1.25458808 |
| 67 | * SMAD3_21741376_ChIP-Seq_EPCs_Human | 1.24564464 |
| 68 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 1.24000335 |
| 69 | * REST_21632747_ChIP-Seq_MESCs_Mouse | 1.23216334 |
| 70 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 1.21979073 |
| 71 | * UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 1.21898991 |
| 72 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.20766376 |
| 73 | WT1_19549856_ChIP-ChIP_CCG9911_Human | 1.20392965 |
| 74 | TAL1_26923725_Chip-Seq_HPCs_Mouse | 1.19708195 |
| 75 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 1.19678320 |
| 76 | IRF4_20064451_ChIP-Seq_CD4+T_Mouse | 1.19017633 |
| 77 | CBP_20019798_ChIP-Seq_JUKART_Human | 1.19017633 |
| 78 | TCF4_23295773_ChIP-Seq_U87_Human | 1.18986572 |
| 79 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.17918244 |
| 80 | TCFCP2L1_18555785_Chip-Seq_ESCs_Mouse | 1.16971210 |
| 81 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 1.16861018 |
| 82 | PRDM14_20953172_ChIP-Seq_ESCs_Human | 1.16698324 |
| 83 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.16036766 |
| 84 | BCAT_22108803_ChIP-Seq_LS180_Human | 1.15120514 |
| 85 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.14603411 |
| 86 | * RUNX2_22187159_ChIP-Seq_PCA_Human | 1.12990955 |
| 87 | NANOG_18555785_Chip-Seq_ESCs_Mouse | 1.12726581 |
| 88 | * TCF3/E2A_22897851_ChIP-Seq_JUKARTE6-1_Human | 1.12543547 |
| 89 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.12517156 |
| 90 | GATA1_19941826_ChIP-Seq_K562_Human | 1.12072918 |
| 91 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 1.11595156 |
| 92 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.11572997 |
| 93 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 1.11391945 |
| 94 | KDM2B_26808549_Chip-Seq_K562_Human | 1.10711931 |
| 95 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 1.10045585 |
| 96 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 1.10020700 |
| 97 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 1.09685709 |
| 98 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.09616023 |
| 99 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 1.09591127 |
| 100 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.09074612 |
| 101 | EBF1_22473956_ChIP-Seq_BONE_MARROW_Mouse | 1.08847639 |
| 102 | DROSHA_22980978_ChIP-Seq_HELA_Human | 1.08470663 |
| 103 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.05703987 |
| 104 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 1.05497022 |
| 105 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 1.05343655 |
| 106 | * FLI1_21867929_ChIP-Seq_TH2_Mouse | 1.04913854 |
| 107 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 1.04707439 |
| 108 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.04569648 |
| 109 | P300_27058665_Chip-Seq_ZR-75-30cells_Human | 1.04088855 |
| 110 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 1.04068156 |
| 111 | KDM2B_26808549_Chip-Seq_REH_Human | 1.03932818 |
| 112 | RUNX_20019798_ChIP-Seq_JUKART_Human | 1.03588195 |
| 113 | SOX2_20726797_ChIP-Seq_SW620_Human | 1.03394646 |
| 114 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 1.03105965 |
| 115 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 1.02758683 |
| 116 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.02367225 |
| 117 | TCF4_22108803_ChIP-Seq_LS180_Human | 1.01684170 |
| 118 | EZH2_27294783_Chip-Seq_NPCs_Mouse | 1.01564782 |
| 119 | CDX2_21402776_ChIP-Seq_INTESTINAL-VILLUS_Mouse | 1.00410298 |
| 120 | SOX2_21211035_ChIP-Seq_LN229_Gbm | 0.99796292 |
| 121 | MEIS1_26923725_Chip-Seq_HEMOGENIC-ENDOTHELIUM_Mouse | 0.99763198 |
| 122 | * LMO2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.99401527 |
| 123 | * GATA2_19941826_ChIP-Seq_K562_Human | 0.99248994 |
| 124 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 0.99145068 |
| 125 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 0.99009771 |
| 126 | NFIB_24661679_ChIP-Seq_LUNG_Mouse | 0.98998104 |
| 127 | FUS_26573619_Chip-Seq_HEK293_Human | 0.98525362 |
| 128 | SMAD3_21741376_ChIP-Seq_HESCs_Human | 0.97589808 |
| 129 | P53_22387025_ChIP-Seq_ESCs_Mouse | 0.97552256 |
| 130 | EP300_20729851_ChIP-Seq_FORBRAIN_MIDBRAIN_LIMB_HEART_Mouse | 0.97456796 |
| 131 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 0.97111180 |
| 132 | NANOG_19829295_ChIP-Seq_ESCs_Human | 0.96970873 |
| 133 | SOX2_19829295_ChIP-Seq_ESCs_Human | 0.96970873 |
| 134 | RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 0.96901670 |
| 135 | TBX20_22080862_ChIP-Seq_HEART_Mouse | 0.96817893 |
| 136 | TBX20_22328084_ChIP-Seq_HEART_Mouse | 0.96817893 |
| 137 | * PU_27001747_Chip-Seq_BMDM_Mouse | 0.96773630 |
| 138 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 0.95772966 |
| 139 | KLF1_20508144_ChIP-Seq_FETAL-LIVER-ERYTHROID_Mouse | 0.95734317 |
| 140 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.95232744 |
| 141 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 0.95128535 |
| 142 | EWS_26573619_Chip-Seq_HEK293_Human | 0.94867028 |
| 143 | * TP53_18474530_ChIP-ChIP_U2OS_Human | 0.94770351 |
| 144 | SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 0.94488546 |
| 145 | KLF4_25985364_ChIP-Seq_ATHEROSCLEROSIS_LESION_Mouse | 0.94369466 |
| 146 | TP63_23658742_ChIP-Seq_EP156T_Human | 0.94324986 |
| 147 | SMAD4_21741376_ChIP-Seq_EPCs_Human | 0.94256302 |
| 148 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 0.94106518 |
| 149 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 0.93133415 |
| 150 | SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 0.92914561 |
| 151 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 0.92086168 |
| 152 | CEBPD_21427703_ChIP-Seq_3T3-L1_Mouse | 0.91751761 |
| 153 | JUND_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.91475877 |
| 154 | TCF3_18467660_ChIP-ChIP_MESCs_Mouse | 0.90899611 |
| 155 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 0.89914969 |
| 156 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 0.89174486 |
| 157 | JUN_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.86935743 |
| 158 | SCL_19346495_ChIP-Seq_HPC-7_Human | 0.86296020 |
| 159 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.83588683 |
| 160 | * SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 0.83476866 |
| 161 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 0.82889401 |
| 162 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 0.82428253 |
| 163 | CTNNB1_20460455_ChIP-Seq_HCT116_Human | 0.82324168 |
| 164 | FOXP2_23625967_ChIP-Seq_PFSK-1_AND_SK-N-MC_Human | 0.82076860 |
| 165 | SOX9_24532713_ChIP-Seq_HFSC_Mouse | 0.81868635 |
| 166 | KDM2B_26808549_Chip-Seq_DND41_Human | 0.81631789 |
| 167 | AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.81589616 |
| 168 | TP53_16413492_ChIP-PET_HCT116_Human | 0.81383841 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0005058_abnormal_lysosome_morphology | 5.81495600 |
| 2 | MP0003172_abnormal_lysosome_physiology | 4.29025455 |
| 3 | MP0000569_abnormal_digit_pigmentation | 3.55995745 |
| 4 | MP0003300_gastrointestinal_ulcer | 3.37514942 |
| 5 | MP0003303_peritoneal_inflammation | 3.12324126 |
| 6 | MP0002653_abnormal_ependyma_morphology | 3.05429872 |
| 7 | MP0001958_emphysema | 2.69925792 |
| 8 | MP0004043_abnormal_pH_regulation | 2.44385203 |
| 9 | MP0005623_abnormal_meninges_morphology | 2.31754919 |
| 10 | MP0003191_abnormal_cellular_cholesterol | 2.12033865 |
| 11 | MP0004858_abnormal_nervous_system | 2.11662774 |
| 12 | MP0000604_amyloidosis | 2.11596165 |
| 13 | MP0009643_abnormal_urine_homeostasis | 1.97724450 |
| 14 | MP0001984_abnormal_olfaction | 1.97664722 |
| 15 | MP0003183_abnormal_peptide_metabolism | 1.94499620 |
| 16 | * MP0003690_abnormal_glial_cell | 1.91104072 |
| 17 | MP0003122_maternal_imprinting | 1.87401663 |
| 18 | MP0002136_abnormal_kidney_physiology | 1.82964997 |
| 19 | MP0001765_abnormal_ion_homeostasis | 1.80537984 |
| 20 | MP0003283_abnormal_digestive_organ | 1.73908159 |
| 21 | MP0008961_abnormal_basal_metabolism | 1.70794737 |
| 22 | MP0003075_altered_response_to | 1.67613216 |
| 23 | MP0005332_abnormal_amino_acid | 1.65677496 |
| 24 | MP0001756_abnormal_urination | 1.63861693 |
| 25 | MP0004019_abnormal_vitamin_homeostasis | 1.63852950 |
| 26 | MP0009764_decreased_sensitivity_to | 1.62779849 |
| 27 | MP0000465_gastrointestinal_hemorrhage | 1.61270115 |
| 28 | MP0002138_abnormal_hepatobiliary_system | 1.60446530 |
| 29 | MP0004147_increased_porphyrin_level | 1.57508579 |
| 30 | MP0005257_abnormal_intraocular_pressure | 1.52612692 |
| 31 | MP0008438_abnormal_cutaneous_collagen | 1.51304892 |
| 32 | MP0003787_abnormal_imprinting | 1.50857039 |
| 33 | * MP0003634_abnormal_glial_cell | 1.50497423 |
| 34 | MP0003195_calcinosis | 1.48737426 |
| 35 | MP0009840_abnormal_foam_cell | 1.47663704 |
| 36 | MP0001501_abnormal_sleep_pattern | 1.47629712 |
| 37 | MP0003880_abnormal_central_pattern | 1.47257591 |
| 38 | MP0003436_decreased_susceptibility_to | 1.47039880 |
| 39 | * MP0002419_abnormal_innate_immunity | 1.46565651 |
| 40 | MP0003091_abnormal_cell_migration | 1.45916331 |
| 41 | MP0003705_abnormal_hypodermis_morpholog | 1.45148211 |
| 42 | MP0003566_abnormal_cell_adhesion | 1.43742132 |
| 43 | MP0001486_abnormal_startle_reflex | 1.42296410 |
| 44 | MP0009046_muscle_twitch | 1.39376911 |
| 45 | MP0004272_abnormal_basement_membrane | 1.39249433 |
| 46 | MP0004270_analgesia | 1.38603447 |
| 47 | MP0003011_delayed_dark_adaptation | 1.37794429 |
| 48 | MP0000343_altered_response_to | 1.37305594 |
| 49 | MP0009745_abnormal_behavioral_response | 1.36900370 |
| 50 | MP0002148_abnormal_hypersensitivity_rea | 1.36664387 |
| 51 | MP0006054_spinal_hemorrhage | 1.36429124 |
| 52 | * MP0002064_seizures | 1.34946442 |
| 53 | MP0004883_abnormal_blood_vessel | 1.33936108 |
| 54 | MP0009278_abnormal_bone_marrow | 1.33846435 |
| 55 | * MP0000920_abnormal_myelination | 1.31816431 |
| 56 | * MP0002998_abnormal_bone_remodeling | 1.31014446 |
| 57 | MP0005360_urolithiasis | 1.30972377 |
| 58 | MP0003632_abnormal_nervous_system | 1.30695720 |
| 59 | MP0001529_abnormal_vocalization | 1.30176013 |
| 60 | MP0005310_abnormal_salivary_gland | 1.30159093 |
| 61 | MP0002572_abnormal_emotion/affect_behav | 1.29558615 |
| 62 | MP0005670_abnormal_white_adipose | 1.29401406 |
| 63 | MP0008875_abnormal_xenobiotic_pharmacok | 1.29111003 |
| 64 | MP0006276_abnormal_autonomic_nervous | 1.27788097 |
| 65 | MP0005671_abnormal_response_to | 1.27691324 |
| 66 | MP0002277_abnormal_respiratory_mucosa | 1.23769670 |
| 67 | MP0000778_abnormal_nervous_system | 1.22811341 |
| 68 | MP0005253_abnormal_eye_physiology | 1.22158119 |
| 69 | MP0005025_abnormal_response_to | 1.19171984 |
| 70 | MP0003635_abnormal_synaptic_transmissio | 1.17789525 |
| 71 | MP0002063_abnormal_learning/memory/cond | 1.17733220 |
| 72 | * MP0002135_abnormal_kidney_morphology | 1.17601715 |
| 73 | MP0001533_abnormal_skeleton_physiology | 1.15668874 |
| 74 | MP0003329_amyloid_beta_deposits | 1.13990046 |
| 75 | MP0009785_altered_susceptibility_to | 1.13388409 |
| 76 | MP0002735_abnormal_chemical_nociception | 1.12964861 |
| 77 | MP0004130_abnormal_muscle_cell | 1.12366081 |
| 78 | MP0004510_myositis | 1.11815215 |
| 79 | MP0002102_abnormal_ear_morphology | 1.11160980 |
| 80 | MP0003656_abnormal_erythrocyte_physiolo | 1.10757377 |
| 81 | MP0002168_other_aberrant_phenotype | 1.10648519 |
| 82 | MP0001970_abnormal_pain_threshold | 1.10540533 |
| 83 | * MP0003631_nervous_system_phenotype | 1.10505612 |
| 84 | MP0005166_decreased_susceptibility_to | 1.10317383 |
| 85 | MP0001986_abnormal_taste_sensitivity | 1.10128415 |
| 86 | MP0002272_abnormal_nervous_system | 1.09572738 |
| 87 | MP0002090_abnormal_vision | 1.09067976 |
| 88 | MP0004142_abnormal_muscle_tone | 1.09066996 |
| 89 | MP0002896_abnormal_bone_mineralization | 1.08712204 |
| 90 | MP0008004_abnormal_stomach_pH | 1.08578599 |
| 91 | MP0002877_abnormal_melanocyte_morpholog | 1.08296202 |
| 92 | MP0005464_abnormal_platelet_physiology | 1.06481805 |
| 93 | MP0002734_abnormal_mechanical_nocicepti | 1.05637840 |
| 94 | MP0003045_fibrosis | 1.05543749 |
| 95 | * MP0002067_abnormal_sensory_capabilities | 1.03445530 |
| 96 | MP0008877_abnormal_DNA_methylation | 1.03422326 |
| 97 | MP0005248_abnormal_Harderian_gland | 1.01936090 |
| 98 | MP0001879_abnormal_lymphatic_vessel | 1.01784630 |
| 99 | * MP0005167_abnormal_blood-brain_barrier | 1.00114833 |
| 100 | MP0004185_abnormal_adipocyte_glucose | 1.00068738 |
| 101 | MP0005551_abnormal_eye_electrophysiolog | 0.99647050 |
| 102 | MP0002733_abnormal_thermal_nociception | 0.98905976 |
| 103 | MP0001968_abnormal_touch/_nociception | 0.98479799 |
| 104 | MP0003448_altered_tumor_morphology | 0.97773471 |
| 105 | * MP0006082_CNS_inflammation | 0.97694795 |
| 106 | MP0005386_behavior/neurological_phenoty | 0.97201246 |
| 107 | MP0004924_abnormal_behavior | 0.97201246 |
| 108 | MP0000639_abnormal_adrenal_gland | 0.96931446 |
| 109 | MP0010368_abnormal_lymphatic_system | 0.95393055 |
| 110 | MP0005083_abnormal_biliary_tract | 0.94637715 |
| 111 | * MP0002452_abnormal_antigen_presenting | 0.94543187 |
| 112 | MP0010678_abnormal_skin_adnexa | 0.94070534 |
| 113 | MP0003279_aneurysm | 0.93379643 |
| 114 | MP0005164_abnormal_response_to | 0.92494453 |
| 115 | MP0005197_abnormal_uvea_morphology | 0.91774872 |
| 116 | MP0004859_abnormal_synaptic_plasticity | 0.91293434 |
| 117 | MP0000427_abnormal_hair_cycle | 0.91167285 |
| 118 | MP0002909_abnormal_adrenal_gland | 0.90646704 |
| 119 | * MP0003633_abnormal_nervous_system | 0.90589262 |
| 120 | * MP0002229_neurodegeneration | 0.90305858 |
| 121 | MP0003828_pulmonary_edema | 0.89603112 |
| 122 | MP0005636_abnormal_mineral_homeostasis | 0.89502436 |
| 123 | MP0005666_abnormal_adipose_tissue | 0.89497202 |
| 124 | MP0004742_abnormal_vestibular_system | 0.89218742 |
| 125 | * MP0002723_abnormal_immune_serum | 0.88941660 |
| 126 | MP0005595_abnormal_vascular_smooth | 0.88390893 |
| 127 | MP0001835_abnormal_antigen_presentation | 0.88192102 |
| 128 | MP0002638_abnormal_pupillary_reflex | 0.87716318 |
| 129 | MP0010386_abnormal_urinary_bladder | 0.87690857 |
| 130 | MP0002928_abnormal_bile_duct | 0.86903976 |
| 131 | * MP0003795_abnormal_bone_structure | 0.86790569 |
| 132 | MP0002295_abnormal_pulmonary_circulatio | 0.86678478 |
| 133 | MP0001440_abnormal_grooming_behavior | 0.86307724 |
| 134 | MP0000230_abnormal_systemic_arterial | 0.85434269 |
| 135 | MP0005085_abnormal_gallbladder_physiolo | 0.85247272 |
| 136 | MP0005377_hearing/vestibular/ear_phenot | 0.85086406 |
| 137 | MP0003878_abnormal_ear_physiology | 0.85086406 |
| 138 | MP0003136_yellow_coat_color | 0.84216263 |
| 139 | MP0000733_abnormal_muscle_development | 0.83110858 |
| 140 | MP0009780_abnormal_chondrocyte_physiolo | 0.81218661 |
| 141 | MP0005000_abnormal_immune_tolerance | 0.78493366 |
| 142 | MP0000383_abnormal_hair_follicle | 0.76953733 |
| 143 | MP0004885_abnormal_endolymph | 0.76773096 |
| 144 | MP0001915_intracranial_hemorrhage | 0.76027747 |
| 145 | MP0002133_abnormal_respiratory_system | 0.75461624 |
| 146 | MP0005388_respiratory_system_phenotype | 0.75461624 |
| 147 | MP0009384_cardiac_valve_regurgitation | 0.74887057 |
| 148 | * MP0005387_immune_system_phenotype | 0.74616473 |
| 149 | * MP0001790_abnormal_immune_system | 0.74616473 |
| 150 | MP0004947_skin_inflammation | 0.74072958 |
| 151 | MP0000767_abnormal_smooth_muscle | 0.73986048 |
| 152 | MP0005076_abnormal_cell_differentiation | 0.73912039 |
| 153 | MP0010307_abnormal_tumor_latency | 0.73745069 |
| 154 | MP0001845_abnormal_inflammatory_respons | 0.73031235 |
| 155 | MP0000371_diluted_coat_color | 0.71944006 |
| 156 | MP0002933_joint_inflammation | 0.68721080 |
| 157 | MP0003724_increased_susceptibility_to | 0.67738917 |
| 158 | MP0001299_abnormal_eye_distance/ | 0.67070970 |
| 159 | MP0004084_abnormal_cardiac_muscle | 0.66609347 |
| 160 | * MP0008469_abnormal_protein_level | 0.64918471 |
| 161 | MP0005375_adipose_tissue_phenotype | 0.64874672 |
| 162 | * MP0002115_abnormal_skeleton_extremities | 0.64011060 |
| 163 | MP0001851_eye_inflammation | 0.63105052 |
| 164 | MP0000858_altered_metastatic_potential | 0.61858031 |
| 165 | MP0005174_abnormal_tail_pigmentation | 0.61558658 |
| 166 | MP0001849_ear_inflammation | 0.61049797 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Increased cerebral lipofuscin (HP:0011813) | 5.36588361 |
| 2 | Vacuolated lymphocytes (HP:0001922) | 4.82638351 |
| 3 | Dysostosis multiplex (HP:0000943) | 4.75762980 |
| 4 | Respiratory insufficiency due to defective ciliary clearance (HP:0200073) | 4.56753495 |
| 5 | Absent/shortened dynein arms (HP:0200106) | 4.55186894 |
| 6 | Dynein arm defect of respiratory motile cilia (HP:0012255) | 4.55186894 |
| 7 | Abnormal ciliary motility (HP:0012262) | 4.46508150 |
| 8 | Abnormal respiratory epithelium morphology (HP:0012253) | 4.29717953 |
| 9 | Abnormal respiratory motile cilium morphology (HP:0005938) | 4.29717953 |
| 10 | Abnormal respiratory motile cilium physiology (HP:0012261) | 4.27788312 |
| 11 | Urinary glycosaminoglycan excretion (HP:0003541) | 4.25136456 |
| 12 | Mucopolysacchariduria (HP:0008155) | 4.25136456 |
| 13 | Increased circulating renin level (HP:0000848) | 4.21885982 |
| 14 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 4.18936520 |
| 15 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 4.03955826 |
| 16 | Abnormality of polysaccharide metabolism (HP:0011012) | 4.03955826 |
| 17 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 4.03955826 |
| 18 | Polyphagia (HP:0002591) | 4.01527481 |
| 19 | Axonal loss (HP:0003447) | 3.92524252 |
| 20 | Hypokalemic alkalosis (HP:0001949) | 3.89531325 |
| 21 | Metabolic alkalosis (HP:0200114) | 3.87546593 |
| 22 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 3.79132159 |
| 23 | Rhinitis (HP:0012384) | 3.64147061 |
| 24 | Abnormality of chloride homeostasis (HP:0011422) | 3.60670251 |
| 25 | Tetany (HP:0001281) | 3.54463826 |
| 26 | Focal segmental glomerulosclerosis (HP:0000097) | 3.49439137 |
| 27 | Hypomagnesemia (HP:0002917) | 3.44130163 |
| 28 | Abnormality of glycolipid metabolism (HP:0010969) | 3.42489572 |
| 29 | Abnormality of liposaccharide metabolism (HP:0010968) | 3.42489572 |
| 30 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 3.42489572 |
| 31 | Hyperactive renin-angiotensin system (HP:0000841) | 3.32265425 |
| 32 | Polyuria (HP:0000103) | 3.15811092 |
| 33 | Abnormality of macrophages (HP:0004311) | 3.09296470 |
| 34 | Chronic hepatic failure (HP:0100626) | 3.01287333 |
| 35 | Neurofibrillary tangles (HP:0002185) | 2.98624459 |
| 36 | True hermaphroditism (HP:0010459) | 2.98373422 |
| 37 | Stomatitis (HP:0010280) | 2.97174126 |
| 38 | Abnormal drinking behavior (HP:0030082) | 2.95246258 |
| 39 | Polydipsia (HP:0001959) | 2.95246258 |
| 40 | Glomerulonephritis (HP:0000099) | 2.94737527 |
| 41 | Glomerulosclerosis (HP:0000096) | 2.93767532 |
| 42 | Abnormal urine output (HP:0012590) | 2.93515444 |
| 43 | Systemic lupus erythematosus (HP:0002725) | 2.92275379 |
| 44 | Abnormality of renal excretion (HP:0011036) | 2.90892683 |
| 45 | Pancreatic fibrosis (HP:0100732) | 2.83537769 |
| 46 | Agitation (HP:0000713) | 2.80720401 |
| 47 | Recurrent abscess formation (HP:0002722) | 2.76928782 |
| 48 | Gout (HP:0001997) | 2.76484363 |
| 49 | Pancreatic cysts (HP:0001737) | 2.76185290 |
| 50 | Abnormality of magnesium homeostasis (HP:0004921) | 2.72727152 |
| 51 | Disinhibition (HP:0000734) | 2.71685398 |
| 52 | Asymmetric septal hypertrophy (HP:0001670) | 2.70715478 |
| 53 | Nephritis (HP:0000123) | 2.69194312 |
| 54 | Abnormal eating behavior (HP:0100738) | 2.66034631 |
| 55 | Mutism (HP:0002300) | 2.64922367 |
| 56 | Nephronophthisis (HP:0000090) | 2.63449576 |
| 57 | Optic neuritis (HP:0100653) | 2.63080695 |
| 58 | Retrobulbar optic neuritis (HP:0100654) | 2.63080695 |
| 59 | Molar tooth sign on MRI (HP:0002419) | 2.60520641 |
| 60 | Abnormality of midbrain morphology (HP:0002418) | 2.60520641 |
| 61 | Arterial tortuosity (HP:0005116) | 2.54055535 |
| 62 | Loss of speech (HP:0002371) | 2.52709424 |
| 63 | Cerebral inclusion bodies (HP:0100314) | 2.51683207 |
| 64 | Hyperventilation (HP:0002883) | 2.51663581 |
| 65 | Orchitis (HP:0100796) | 2.50020756 |
| 66 | Medial flaring of the eyebrow (HP:0010747) | 2.48320161 |
| 67 | Hemiplegia (HP:0002301) | 2.47762629 |
| 68 | Retinal atrophy (HP:0001105) | 2.47582838 |
| 69 | Bronchiectasis (HP:0002110) | 2.46864750 |
| 70 | Myositis (HP:0100614) | 2.45293366 |
| 71 | Abnormality of renin-angiotensin system (HP:0000847) | 2.44542923 |
| 72 | Supranuclear gaze palsy (HP:0000605) | 2.41356680 |
| 73 | Gait imbalance (HP:0002141) | 2.39493065 |
| 74 | Neuronal loss in central nervous system (HP:0002529) | 2.38296643 |
| 75 | Tubular atrophy (HP:0000092) | 2.35584718 |
| 76 | Genetic anticipation (HP:0003743) | 2.35443048 |
| 77 | Inappropriate behavior (HP:0000719) | 2.33107507 |
| 78 | Recurrent bacterial skin infections (HP:0005406) | 2.30835816 |
| 79 | Abnormality of the renal medulla (HP:0100957) | 2.30551738 |
| 80 | Nasal polyposis (HP:0100582) | 2.28860446 |
| 81 | Metaphyseal cupping (HP:0003021) | 2.28106067 |
| 82 | Occipital encephalocele (HP:0002085) | 2.27403605 |
| 83 | Hypercalciuria (HP:0002150) | 2.24845198 |
| 84 | Primitive reflexes (palmomental, snout, glabellar) (HP:0002476) | 2.24627819 |
| 85 | Vascular tortuosity (HP:0004948) | 2.23869200 |
| 86 | Cervical subluxation (HP:0003308) | 2.23866663 |
| 87 | Congenital primary aphakia (HP:0007707) | 2.23769839 |
| 88 | Cerebral aneurysm (HP:0004944) | 2.21764718 |
| 89 | J-shaped sella turcica (HP:0002680) | 2.21239384 |
| 90 | Abnormality of the nasal mucosa (HP:0000433) | 2.21231309 |
| 91 | Renal salt wasting (HP:0000127) | 2.21146390 |
| 92 | Hyperaldosteronism (HP:0000859) | 2.20142565 |
| 93 | Progressive cerebellar ataxia (HP:0002073) | 2.19546801 |
| 94 | Abnormality of proline metabolism (HP:0010907) | 2.18186616 |
| 95 | Hydroxyprolinuria (HP:0003080) | 2.18186616 |
| 96 | Eczematoid dermatitis (HP:0000976) | 2.18122968 |
| 97 | Decreased circulating renin level (HP:0003351) | 2.16232003 |
| 98 | Recurrent gram-negative bacterial infections (HP:0005420) | 2.14749719 |
| 99 | Nephrogenic diabetes insipidus (HP:0009806) | 2.12888827 |
| 100 | Mesangial abnormality (HP:0001966) | 2.12381697 |
| 101 | Ovoid vertebral bodies (HP:0003300) | 2.11428725 |
| 102 | Global brain atrophy (HP:0002283) | 2.10964971 |
| 103 | Hip dysplasia (HP:0001385) | 2.10707193 |
| 104 | Diplopia (HP:0000651) | 2.08805276 |
| 105 | Abnormality of binocular vision (HP:0011514) | 2.08805276 |
| 106 | Genital tract atresia (HP:0001827) | 2.08795067 |
| 107 | Amyloidosis (HP:0011034) | 2.06261879 |
| 108 | Absent speech (HP:0001344) | 2.05058870 |
| 109 | Vaginal atresia (HP:0000148) | 2.03936335 |
| 110 | Abolished electroretinogram (ERG) (HP:0000550) | 2.03853570 |
| 111 | * Increased CSF protein (HP:0002922) | 2.03283232 |
| 112 | Congenital hepatic fibrosis (HP:0002612) | 2.02549710 |
| 113 | Abnormality of purine metabolism (HP:0004352) | 2.01885547 |
| 114 | Hypophosphatemia (HP:0002148) | 2.00966999 |
| 115 | Hematochezia (HP:0002573) | 2.00067371 |
| 116 | Pathologic fracture (HP:0002756) | 1.98697675 |
| 117 | Amyotrophic lateral sclerosis (HP:0007354) | 1.97856291 |
| 118 | Persistence of primary teeth (HP:0006335) | 1.96245532 |
| 119 | Chronic bronchitis (HP:0004469) | 1.95348100 |
| 120 | Hypokalemia (HP:0002900) | 1.95258850 |
| 121 | Interstitial pulmonary disease (HP:0006530) | 1.90473938 |
| 122 | Elevated erythrocyte sedimentation rate (HP:0003565) | 1.90292081 |
| 123 | * Peripheral demyelination (HP:0011096) | 1.89704425 |
| 124 | Distal upper limb amyotrophy (HP:0007149) | 1.89673189 |
| 125 | Upper limb amyotrophy (HP:0009129) | 1.89673189 |
| 126 | Tubulointerstitial abnormality (HP:0001969) | 1.87945823 |
| 127 | Lymphangioma (HP:0100764) | 1.85916291 |
| 128 | Stage 5 chronic kidney disease (HP:0003774) | 1.85201663 |
| 129 | Progressive visual loss (HP:0000529) | 1.85129456 |
| 130 | Tubulointerstitial fibrosis (HP:0005576) | 1.84197258 |
| 131 | Hand muscle atrophy (HP:0009130) | 1.83454844 |
| 132 | Atrophy/Degeneration involving the corticospinal tracts (HP:0007372) | 1.82599387 |
| 133 | Degeneration of the lateral corticospinal tracts (HP:0002314) | 1.82599387 |
| 134 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 1.82456901 |
| 135 | Recurrent sinusitis (HP:0011108) | 1.81561493 |
| 136 | Drooling (HP:0002307) | 1.81361356 |
| 137 | Cystic liver disease (HP:0006706) | 1.80943836 |
| 138 | Spondylolisthesis (HP:0003302) | 1.80629163 |
| 139 | Alkalosis (HP:0001948) | 1.80537857 |
| 140 | Abnormality of potassium homeostasis (HP:0011042) | 1.80140529 |
| 141 | Excessive salivation (HP:0003781) | 1.80027588 |
| 142 | Increased purine levels (HP:0004368) | 1.78084344 |
| 143 | Hyperuricemia (HP:0002149) | 1.78084344 |
| 144 | Male pseudohermaphroditism (HP:0000037) | 1.77030949 |
| 145 | Action tremor (HP:0002345) | 1.75871276 |
| 146 | Obstructive lung disease (HP:0006536) | 1.72853371 |
| 147 | Chronic obstructive pulmonary disease (HP:0006510) | 1.72853371 |
| 148 | Turricephaly (HP:0000262) | 1.72754711 |
| 149 | Infertility (HP:0000789) | 1.72572998 |
| 150 | Aplasia/Hypoplasia of the tibia (HP:0005772) | 1.72561940 |
| 151 | Apathy (HP:0000741) | 1.71670134 |
| 152 | Abnormality of the lumbar spine (HP:0100712) | 1.71275373 |
| 153 | Thoracic kyphosis (HP:0002942) | 1.71263774 |
| 154 | Metaphyseal dysplasia (HP:0100255) | 1.71112682 |
| 155 | Myocardial infarction (HP:0001658) | 1.70916849 |
| 156 | Widely spaced teeth (HP:0000687) | 1.69517273 |
| 157 | Diminished motivation (HP:0000745) | 1.69353630 |
| 158 | Abnormality of the periventricular white matter (HP:0002518) | 1.67842506 |
| 159 | Protuberant abdomen (HP:0001538) | 1.67506184 |
| 160 | Febrile seizures (HP:0002373) | 1.67266490 |
| 161 | Osteolytic defects of the phalanges of the hand (HP:0009771) | 1.67105043 |
| 162 | Osteolytic defects of the hand bones (HP:0009699) | 1.67105043 |
| 163 | Nephropathy (HP:0000112) | 1.66675998 |
| 164 | Failure to thrive in infancy (HP:0001531) | 1.66085358 |
| 165 | Hypoplasia of the odontoid process (HP:0003311) | 1.64221982 |
| 166 | Rapidly progressive (HP:0003678) | 1.63578139 |
| 167 | Femoral bowing (HP:0002980) | 1.61669056 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | WNK4 | 4.18764323 |
| 2 | FRK | 3.38199701 |
| 3 | TRIB3 | 3.26069390 |
| 4 | OXSR1 | 2.94699811 |
| 5 | ACVR1B | 2.44215249 |
| 6 | WNK3 | 2.32627383 |
| 7 | PRKD3 | 2.31502503 |
| 8 | TGFBR2 | 2.25414193 |
| 9 | CAMK1G | 2.22370542 |
| 10 | EPHA3 | 2.17224837 |
| 11 | CASK | 2.08095145 |
| 12 | NTRK1 | 2.07945842 |
| 13 | ADRBK2 | 1.99333562 |
| 14 | GRK7 | 1.99057854 |
| 15 | RIPK4 | 1.98373598 |
| 16 | STK39 | 1.97097509 |
| 17 | CAMK1D | 1.96585244 |
| 18 | MAP3K4 | 1.94843456 |
| 19 | RIPK1 | 1.79722110 |
| 20 | MAP3K9 | 1.74830357 |
| 21 | MAP3K2 | 1.66526059 |
| 22 | EPHB1 | 1.65368569 |
| 23 | PKN2 | 1.60150597 |
| 24 | BCR | 1.58230175 |
| 25 | WNK1 | 1.50748834 |
| 26 | PTK6 | 1.50210254 |
| 27 | EPHA4 | 1.48495448 |
| 28 | KSR2 | 1.44303286 |
| 29 | BMX | 1.41515252 |
| 30 | CSNK1G2 | 1.32848147 |
| 31 | PTK2 | 1.30037392 |
| 32 | PAK4 | 1.29695232 |
| 33 | ERN1 | 1.29645951 |
| 34 | TTN | 1.29003083 |
| 35 | MAP3K13 | 1.25633739 |
| 36 | PDGFRA | 1.24546191 |
| 37 | SGK3 | 1.23415680 |
| 38 | MAPK13 | 1.23036231 |
| 39 | CAMKK1 | 1.19203836 |
| 40 | SGK494 | 1.17213033 |
| 41 | SGK223 | 1.17213033 |
| 42 | PAK6 | 1.16569084 |
| 43 | KIT | 1.12824053 |
| 44 | MARK1 | 1.12465224 |
| 45 | TAOK3 | 1.09784911 |
| 46 | LRRK2 | 1.08637754 |
| 47 | PRKCH | 1.07884014 |
| 48 | JAK1 | 1.04934166 |
| 49 | CSF1R | 1.04905733 |
| 50 | TBK1 | 1.04016077 |
| 51 | MET | 1.03990248 |
| 52 | PTK2B | 1.00006235 |
| 53 | NEK9 | 0.99995695 |
| 54 | PDPK1 | 0.98529513 |
| 55 | TRIM28 | 0.96241947 |
| 56 | PDGFRB | 0.95936677 |
| 57 | SCYL2 | 0.95540155 |
| 58 | YES1 | 0.95522625 |
| 59 | PDK4 | 0.95283932 |
| 60 | PDK3 | 0.95283932 |
| 61 | JAK2 | 0.94519081 |
| 62 | STK38 | 0.92842918 |
| 63 | IRAK3 | 0.91418879 |
| 64 | EPHB2 | 0.91257196 |
| 65 | TNIK | 0.90848322 |
| 66 | MAP2K4 | 0.90831022 |
| 67 | MAP2K7 | 0.90208816 |
| 68 | STK10 | 0.89305755 |
| 69 | FER | 0.88615384 |
| 70 | SGK2 | 0.88449132 |
| 71 | FGR | 0.88377895 |
| 72 | PIK3CG | 0.88287765 |
| 73 | TXK | 0.87079027 |
| 74 | PIK3CA | 0.86682249 |
| 75 | MAPK7 | 0.86665777 |
| 76 | IKBKE | 0.85841332 |
| 77 | GSK3A | 0.85439852 |
| 78 | PDK1 | 0.85285493 |
| 79 | RET | 0.85193186 |
| 80 | INSRR | 0.83880509 |
| 81 | CAMKK2 | 0.83724057 |
| 82 | PDK2 | 0.83539633 |
| 83 | DMPK | 0.81975783 |
| 84 | NTRK2 | 0.81971962 |
| 85 | IRAK2 | 0.81812966 |
| 86 | PINK1 | 0.80915158 |
| 87 | TYK2 | 0.80905094 |
| 88 | DAPK2 | 0.80733284 |
| 89 | EGFR | 0.80382571 |
| 90 | MAP3K14 | 0.79232906 |
| 91 | TESK1 | 0.78939990 |
| 92 | NTRK3 | 0.77949342 |
| 93 | SYK | 0.77542554 |
| 94 | DYRK1A | 0.75869656 |
| 95 | KSR1 | 0.75679521 |
| 96 | TNK2 | 0.74952563 |
| 97 | MST1R | 0.74933752 |
| 98 | FES | 0.74702787 |
| 99 | CSNK1G3 | 0.74678598 |
| 100 | LYN | 0.74523351 |
| 101 | CSNK1A1L | 0.73654574 |
| 102 | PNCK | 0.72149371 |
| 103 | MAP3K1 | 0.72116768 |
| 104 | HCK | 0.71165504 |
| 105 | BMPR2 | 0.70166200 |
| 106 | GRK1 | 0.69693279 |
| 107 | DYRK2 | 0.68865902 |
| 108 | MAPK15 | 0.67742220 |
| 109 | MAP3K6 | 0.67620817 |
| 110 | MOS | 0.67211551 |
| 111 | LCK | 0.65954184 |
| 112 | STK11 | 0.65739595 |
| 113 | ZAP70 | 0.65598174 |
| 114 | TEC | 0.64937851 |
| 115 | ADRBK1 | 0.63177694 |
| 116 | SGK1 | 0.62790993 |
| 117 | CDK5 | 0.62648158 |
| 118 | FYN | 0.62417689 |
| 119 | IKBKB | 0.62404420 |
| 120 | TRPM7 | 0.62346938 |
| 121 | IRAK1 | 0.62179113 |
| 122 | CDK6 | 0.61770097 |
| 123 | CAMK2A | 0.61333205 |
| 124 | MAP3K3 | 0.60716735 |
| 125 | TYRO3 | 0.59930323 |
| 126 | DYRK1B | 0.59869595 |
| 127 | IRAK4 | 0.59427830 |
| 128 | CSNK1G1 | 0.59150649 |
| 129 | MAP2K3 | 0.58974896 |
| 130 | PLK2 | 0.58902283 |
| 131 | BMPR1B | 0.58352277 |
| 132 | PRKCG | 0.58229112 |
| 133 | TIE1 | 0.56489395 |
| 134 | BLK | 0.56425025 |
| 135 | PAK3 | 0.55860812 |
| 136 | DYRK3 | 0.55604433 |
| 137 | TAOK1 | 0.55012180 |
| 138 | PRKCZ | 0.54964462 |
| 139 | CSK | 0.54591286 |
| 140 | MAP3K11 | 0.53958563 |
| 141 | PAK2 | 0.53465168 |
| 142 | BTK | 0.52767748 |
| 143 | ERBB2 | 0.51569080 |
| 144 | IGF1R | 0.51188226 |
| 145 | SRC | 0.51067600 |
| 146 | MARK2 | 0.50209710 |
| 147 | ICK | 0.48586718 |
| 148 | ITK | 0.48276440 |
| 149 | MARK3 | 0.44999956 |
| 150 | INSR | 0.44881618 |
| 151 | ERBB3 | 0.43449433 |
| 152 | MATK | 0.42473240 |
| 153 | PRKCE | 0.42450824 |
| 154 | ABL2 | 0.39837680 |
| 155 | SIK2 | 0.38647572 |
| 156 | ABL1 | 0.37872083 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 3.29836047 |
| 2 | * Lysosome_Homo sapiens_hsa04142 | 3.01580991 |
| 3 | Other glycan degradation_Homo sapiens_hsa00511 | 2.18393373 |
| 4 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 1.96163144 |
| 5 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 1.84444097 |
| 6 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 1.65952829 |
| 7 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 1.65863981 |
| 8 | Nicotine addiction_Homo sapiens_hsa05033 | 1.58594127 |
| 9 | Phagosome_Homo sapiens_hsa04145 | 1.49748582 |
| 10 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.45840703 |
| 11 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 1.44917207 |
| 12 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 1.35200987 |
| 13 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 1.32401410 |
| 14 | Leishmaniasis_Homo sapiens_hsa05140 | 1.29620361 |
| 15 | Osteoclast differentiation_Homo sapiens_hsa04380 | 1.28033241 |
| 16 | Tuberculosis_Homo sapiens_hsa05152 | 1.27236307 |
| 17 | Ether lipid metabolism_Homo sapiens_hsa00565 | 1.26391934 |
| 18 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 1.26017691 |
| 19 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.25257099 |
| 20 | Morphine addiction_Homo sapiens_hsa05032 | 1.24668291 |
| 21 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 1.22342160 |
| 22 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 1.22012218 |
| 23 | Mineral absorption_Homo sapiens_hsa04978 | 1.19050080 |
| 24 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 1.18637989 |
| 25 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 1.17836742 |
| 26 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 1.17798660 |
| 27 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 1.15510144 |
| 28 | Phototransduction_Homo sapiens_hsa04744 | 1.13916615 |
| 29 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 1.10779838 |
| 30 | Amoebiasis_Homo sapiens_hsa05146 | 1.09355727 |
| 31 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 1.07617302 |
| 32 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 1.06625643 |
| 33 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 1.05873785 |
| 34 | Glutamatergic synapse_Homo sapiens_hsa04724 | 1.05040017 |
| 35 | Histidine metabolism_Homo sapiens_hsa00340 | 1.04812993 |
| 36 | Asthma_Homo sapiens_hsa05310 | 1.04446472 |
| 37 | GABAergic synapse_Homo sapiens_hsa04727 | 1.03560379 |
| 38 | Circadian entrainment_Homo sapiens_hsa04713 | 1.01806959 |
| 39 | Focal adhesion_Homo sapiens_hsa04510 | 1.00027189 |
| 40 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 0.99989857 |
| 41 | Pertussis_Homo sapiens_hsa05133 | 0.99177563 |
| 42 | Gastric acid secretion_Homo sapiens_hsa04971 | 0.98919205 |
| 43 | ECM-receptor interaction_Homo sapiens_hsa04512 | 0.98211024 |
| 44 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.97973329 |
| 45 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.96807192 |
| 46 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 0.96280800 |
| 47 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.94911166 |
| 48 | ABC transporters_Homo sapiens_hsa02010 | 0.94313030 |
| 49 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 0.93994180 |
| 50 | Cocaine addiction_Homo sapiens_hsa05030 | 0.93630459 |
| 51 | Endocytosis_Homo sapiens_hsa04144 | 0.93057744 |
| 52 | Glioma_Homo sapiens_hsa05214 | 0.92802291 |
| 53 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.92705089 |
| 54 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.92311377 |
| 55 | Bile secretion_Homo sapiens_hsa04976 | 0.91333868 |
| 56 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.90196942 |
| 57 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 0.89863206 |
| 58 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.89773085 |
| 59 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.88585270 |
| 60 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.88296869 |
| 61 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.87685614 |
| 62 | Nitrogen metabolism_Homo sapiens_hsa00910 | 0.87108567 |
| 63 | Butanoate metabolism_Homo sapiens_hsa00650 | 0.86630810 |
| 64 | Long-term depression_Homo sapiens_hsa04730 | 0.86165423 |
| 65 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.85217199 |
| 66 | Graft-versus-host disease_Homo sapiens_hsa05332 | 0.83762832 |
| 67 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.83576167 |
| 68 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.82658195 |
| 69 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 0.81526552 |
| 70 | Serotonergic synapse_Homo sapiens_hsa04726 | 0.80069033 |
| 71 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.79817301 |
| 72 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 0.79529666 |
| 73 | Legionellosis_Homo sapiens_hsa05134 | 0.78905544 |
| 74 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.78721922 |
| 75 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.78086570 |
| 76 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 0.78078329 |
| 77 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.77453364 |
| 78 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.75275688 |
| 79 | Dopaminergic synapse_Homo sapiens_hsa04728 | 0.75208632 |
| 80 | Protein digestion and absorption_Homo sapiens_hsa04974 | 0.74287801 |
| 81 | Insulin secretion_Homo sapiens_hsa04911 | 0.74285315 |
| 82 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.74189108 |
| 83 | Cholinergic synapse_Homo sapiens_hsa04725 | 0.73883507 |
| 84 | Malaria_Homo sapiens_hsa05144 | 0.73844268 |
| 85 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.73144769 |
| 86 | Allograft rejection_Homo sapiens_hsa05330 | 0.73083720 |
| 87 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 0.72705657 |
| 88 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.69609271 |
| 89 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.69584522 |
| 90 | Salmonella infection_Homo sapiens_hsa05132 | 0.69477556 |
| 91 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 0.68500057 |
| 92 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 0.67358764 |
| 93 | Platelet activation_Homo sapiens_hsa04611 | 0.66527882 |
| 94 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.65918814 |
| 95 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.65627219 |
| 96 | Renin secretion_Homo sapiens_hsa04924 | 0.65329652 |
| 97 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 0.65077826 |
| 98 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.64485233 |
| 99 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.64398676 |
| 100 | Shigellosis_Homo sapiens_hsa05131 | 0.63748195 |
| 101 | PPAR signaling pathway_Homo sapiens_hsa03320 | 0.63541295 |
| 102 | * Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.63175378 |
| 103 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.62993632 |
| 104 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.62906715 |
| 105 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.61325118 |
| 106 | Taste transduction_Homo sapiens_hsa04742 | 0.61172023 |
| 107 | Antigen processing and presentation_Homo sapiens_hsa04612 | 0.60333489 |
| 108 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.59316501 |
| 109 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.59237451 |
| 110 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.58850223 |
| 111 | Tryptophan metabolism_Homo sapiens_hsa00380 | 0.58516712 |
| 112 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.58263804 |
| 113 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.57961415 |
| 114 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.57688984 |
| 115 | Olfactory transduction_Homo sapiens_hsa04740 | 0.57628101 |
| 116 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 0.57471469 |
| 117 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.57402775 |
| 118 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.57161940 |
| 119 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.56871984 |
| 120 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.56684538 |
| 121 | Insulin resistance_Homo sapiens_hsa04931 | 0.56183198 |
| 122 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.55150704 |
| 123 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 0.55129737 |
| 124 | Lysine degradation_Homo sapiens_hsa00310 | 0.54991474 |
| 125 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.54931361 |
| 126 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.54445451 |
| 127 | Adherens junction_Homo sapiens_hsa04520 | 0.54402230 |
| 128 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.54211247 |
| 129 | Steroid biosynthesis_Homo sapiens_hsa00100 | 0.53726469 |
| 130 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.52783988 |
| 131 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.52669263 |
| 132 | Amphetamine addiction_Homo sapiens_hsa05031 | 0.51599184 |
| 133 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.51538268 |
| 134 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.49332091 |
| 135 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.48663300 |
| 136 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.48574767 |
| 137 | Salivary secretion_Homo sapiens_hsa04970 | 0.47266627 |
| 138 | Fatty acid metabolism_Homo sapiens_hsa01212 | 0.45883008 |
| 139 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.45867293 |
| 140 | Prion diseases_Homo sapiens_hsa05020 | 0.44586458 |
| 141 | Bladder cancer_Homo sapiens_hsa05219 | 0.43716824 |
| 142 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.43558618 |
| 143 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 0.42682908 |
| 144 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.41861793 |
| 145 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 0.41799332 |
| 146 | Fatty acid degradation_Homo sapiens_hsa00071 | 0.40811563 |
| 147 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.40777847 |
| 148 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.40191077 |
| 149 | Endometrial cancer_Homo sapiens_hsa05213 | 0.39426762 |
| 150 | Axon guidance_Homo sapiens_hsa04360 | 0.39253928 |
| 151 | cAMP signaling pathway_Homo sapiens_hsa04024 | 0.38583715 |
| 152 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 0.38285178 |
| 153 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 0.38276009 |
| 154 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.37694510 |

